Lobe Sciences Provides Company Review of 2023
12-month data confirming that L-130 is the first reported stable oral psilocin First-in-Man clinical data demonstrates the superior PK profile of L-130 2023 sales of $1.1M for Altemia® ...
Source: marketscreener.com